SecBot SecBot
3 ·Filed Nov 10, 2026

SPRO

Spero Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 4h ago SEC0001193125-26-455868
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Monitor future Form 4 filings for any insider transactions by William Ho, which could signal his view on the company's prospects. The appointment of a new director is routine and does not warrant immediate action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$1.02
T+0 close · Nov 10, 2026 · via day close
Latest settled
−1.96%
T+1 · $1.00
Vs SPY
−1.61%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $1.02entry
  2. T+1 · 5d ago −1.96%α −1.61% · $1.00
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

William Ho, M.D., Ph.D., filed a Form 3 initial statement of beneficial ownership with Spero Therapeutics, Inc., indicating he has become a director (and possibly officer or 10% shareholder) of the company. The filing is accompanied by a standard power of attorney authorizing company officers to execute future Section 16 filings on his behalf. This is a routine administrative filing with no material financial impact.

Key Facts

  • William Ho filed a Form 3 initial statement of beneficial ownership with Spero Therapeutics, Inc.
  • The filing was made on November 10, 2026, with a period of report of November 10, 2026.
  • A power of attorney (Exhibit 24.1) was executed on November 9, 2026, authorizing Esther Rajavelu, Sheila Finan, and Maegan Deare to execute Forms 3, 4, and 5 on behalf of William Ho.
  • William Ho is identified as a director of Spero Therapeutics, Inc.

Financial Impact

No financial figures disclosed in the filing.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-455868
Document: 0001193125-26-455868-index-headers.html0001193125-26-455868
Document: 0001193125-26-455868-index.html0001193125-26-455868
Document: 0001193125-26-455868.txt0001193125-26-455868

Track record

17 reports on SPRO

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.59% at T+20 after the Mar 26, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $0.9999 Now $0.9460 −5.39% settles Nov 20
  2. Nov 10, 20266d ago 3 Neutral 2/10 Viewing Entry $1.02 Now $0.9460 −7.25% settles Nov 18
  3. Nov 10, 20266d ago 8-K Neutral 2/10 Entry $1.02 Now $0.9460 −7.25% settles Nov 18
  4. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $1.17 to $1.07 Now $0.9460 −19.15% ▼ −8.55% −7.83% vs SPY
  5. Sep 11, 20269w ago EFFECT Bearish 7/10 Entry $1.13 to $1.13 Now $0.9460 +16.28% · 0.00% −0.34% vs SPY
  6. Aug 28, 202611w ago 8-K Bearish 7/10 Entry $1.22 to $1.19 Now $0.9460 +22.46% ▲ +2.46% +2.32% vs SPY
  7. Aug 28, 202611w ago S-3 Bearish 7/10 Entry $1.22 to $1.19 Now $0.9460 +22.46% ▲ +2.46% +2.32% vs SPY
  8. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $1.24 to $1.22 Now $0.9460 −23.71% ▼ −1.61% +0.35% vs SPY
  9. Jul 14, 202617w ago 8-K Bullish 8/10 Entry $1.70 to $1.44 Now $0.9460 −44.35% ▼ −15.29% −14.00% vs SPY
  10. Jul 14, 202617w ago Press Release Bullish 7/10 Entry $1.70 to $1.44 Now $0.9460 −44.35% ▼ −15.29% −14.00% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (10h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026